Imperative Care vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Imperative Care is a commercial-stage MedTech company with FDA-cleared Zoom Stroke System used in 78,000+ procedures; raised $100M financing in March 2026 to expand its stroke thrombectomy portfolio and develop the Telos robotic stroke treatment.
About
Imperative Care is a commercial-stage medical technology company focused on advancing treatments for stroke and other thromboembolic diseases — conditions caused by blood clot formation in arteries and veins. Founded and headquartered in Campbell, California, Imperative Care designs and manufactures catheter-based devices for mechanical thrombectomy: the surgical removal of blood clots that cause strokes and other life-threatening vascular events. Its products are engineered to improve access to clots, aspiration performance, and overall procedure efficiency during time-critical stroke interventions.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.